Scopolamine Transdermal System — FDA Drug Shortage

No longer listed by FDA — Padagis US LLC

The FDA lists a drug shortage record for Scopolamine Transdermal System (transdermal system) from Padagis US LLC with status No longer listed by FDA. The shortage was first posted on Nov 3, 2025.

Shortage details

Status
No longer listed by FDA
Company
Padagis US LLC
Package NDC
45802-580-46
Dosage Form
Transdermal System
Presentation
Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46)
Initial Posting
Nov 3, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.